←
Katherine Cheung442 posts
Katherine Cheung avatar

Katherine Cheung

@Katherine_Chg

PhD student in Bioethics & Health Policy at @JohnsHopkinsSPH @bermaninstitute | psychedelic ethics 🌱, research ethics

◷ Joined March 2023▧ 49 Photos and videos
Katherine Cheung avatar
Katherine Cheung@Katherine_Chg·Nov 12

In particular, many websites advertised possible medical and non-medical benefits of psilocybin services, raising questions about how online advertising, especially related to medical applications, may shape public expectations of psilocybin services.

Katherine Cheung avatar
Katherine Cheung@Katherine_Chg·Nov 12

We analyzed claims made in service centers' websites, and found substantial variation in how centers described psilocybin's benefits, risks, mechanisms, evidence base, and legal status.

Katherine Cheung avatar
Katherine Cheung@Katherine_Chg·Nov 12

With early data from the Oregon Health Authority showing that clients report seeking out psilocybin services in Oregon for a wide range of motivations, one question is how service centers are representing their services to the public.

Post attachment
David B. Yaden avatar
⟳ Katherine Cheung retweeted
David B. Yaden@ExistWell·Nov 11

This is an unusual & interesting survey in this space, and I invite you to take it. The idea emerged at a @psychedelethics meeting at Oxford when the group realized we don't have data on what groups in the field think should received more funding/attention. Share your ideas!

🍄 @JHPsychedelics PSYCHEDELIC STAKEHOLDER SURVEY 🔬 There are more promising psychedelic research projects than there is funding. What should take priority? Our new survey is open to anyone with a personal or professional interest in psychedelic science [link below]

Post attachment
Eddie Talks Drugs avatar
⟳ Katherine Cheung retweeted
Eddie Talks Drugs@eddietalksdrugs·Oct 29

🍄 @JHPsychedelics PSYCHEDELIC STAKEHOLDER SURVEY 🔬 There are more promising psychedelic research projects than there is funding. What should take priority? Our new survey is open to anyone with a personal or professional interest in psychedelic science [link below]

Post attachment
Sean Goldy avatar
⟳ Katherine Cheung retweeted
Sean Goldy@SeanPGoldy·Oct 21

‼️ New paper! MDMA "blue Mondays" & "suicide Tuesdays" are familiar phrases in recreational MDMA culture, describing low points in the days post-use. But do these aftereffects actually exist? Current research shows conflicting results. Thread👇

Post attachment
William Choi avatar
⟳ Katherine Cheung retweeted
William Choi@willjwchoi·Oct 16

doi.org/10.1007/s12152-026-0… Beyond excited to announce this piece just published in @NeuroethicsJ! During my research year at @JHPsychedelics, I had the privilege to co-facilitate prep, dosing and integration sessions for a number of participants in one of the psilocybin trials

Katherine Cheung avatar
Katherine Cheung@Katherine_Chg·Oct 15

"Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network" frontiersin.org/journals/psy…

David B. Yaden avatar
⟳ Katherine Cheung retweeted
David B. Yaden@ExistWell·Oct 9

A comprehensive review of bioethical progress and need for further work on psychedelic research and potential clinical applications across screening, informed consent, dosing, follow-up, & more. Work led by @Katherine_Chg w/ @eddietalksdrugs and me. Check out the thread and link:

A growing body of bioethical work has examined ethical issues related to the use of psychedelics in clinical research. With @eddietalksdrugs and @ExistWell, we try to take stock in our state-of-the-field review, published in JME Practical Bioethics.

Post attachment
Katherine Cheung avatar
Katherine Cheung@Katherine_Chg·Oct 9

While we have focused our review on the ethical challenges relevant to clinical trials, many of the considerations we discuss will remain relevant as psychedelics move towards clinical applications.